Friday , October 20 2017
Home / Resources / Clinical Presentations / Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5

DCMS51_HS_Image

This week we continue with Part 4 of our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents. Slides this week cover Exenatide, a synthetic version of Exendin-4 which is found in the saliva of the Gila monster….

Link to download (.ppt format): Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5

Other sets in this series:

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 1 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 2 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5 of 5

 

Check out all of Diabetes In Control’s slide collections at our new Clinical Presentations Library.